Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 2-4 December 2025

Veterinary medicines European public assessment report (EPAR): Firocoxib CP-Pharma, firocoxib, Status: Opinion

Summary of opinion: Dexdomitor, 04/12/2025 Positive

Applications for new human medicines under evaluation: December 2025

Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use'

All languages - Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) - Revision 5

Opinion/decision on a Paediatric investigation plan (PIP): Cibinqo, abrocitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: EMA/PE/0000183059

Opinion/decision on a Paediatric investigation plan (PIP): Eurneffy, adrenaline (epinephrine), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000221076